Article
Utilize the first AI software for diagnosing DLBCL
GTC is the first and only diagnostic lab to deploy true artificial intelligence (AI) software for classifications of lymphoma. Do not accept partial results, send
August 5, 2020 11:00 am
genomic testing
Read More »
Article
Hackensack Meridian Health Partners with GTC to Establish a Reference Laboratory Offering State-of-the-Art Genomic Precision Testing
IRVINE, Calif. and EDISON, N.J., July 22, 2020 /PRNewswire/ — Hackensack Meridian Health (HMH) in Edison, New Jersey, and Genomic Testing Cooperative (GTC), Irvine, California, announced
July 22, 2020 4:00 am
Press Releases
GTC research is being presented at ASCO 2020
GTC research is being presented at ASCO 2020 in the following three abstracts. 1. FGFR expression, fusion and mutation as detected by NGS sequencing of
May 20, 2020 9:50 am
Genomics
GTC was featured in the Orange County Business Journal again
GTC featured in the Orange County Business Journal on February 3, 2020
February 26, 2020 11:00 am
Press Releases
New Collaboration to Offer Liquid Biopsy Testing
Genomic Testing Cooperative (GTC) and C2i Genomics Announce Collaboration to Offer Liquid Biopsy Testing for Staging and Monitoring Solid Tumors Based on Pattern Recognition of
January 14, 2020 4:00 am
Press Releases
Genomic Testing Cooperative (GTC) Receives Medicare (Palmetto GBA) Coverage for GTC-Solid Tumor Profile (434 gene) Test
GTC Solid Tumor Profile™ with 434 genes test is now covered by Medicare for patients with a wide range of solid tumor cancers Irvine, California–
January 7, 2020 4:00 am
Press Releases
Genomic Testing Cooperative to Present at American Society of Hematology Annual Meeting 2019
Genomic Testing Cooperative to Present Data on its Proprietary RNA Profiling and Artificial Intelligence Algorithms at American Society of Hematology Annual Meeting Irvine, California– December
December 3, 2019 4:59 am
Genomics
GTC was honored to be featured in the Orange County Business Journal
GTC featured in the Orange County Business Journal on September 30, 2019 [Click image to enlarge]
October 16, 2019 10:24 am
Innovation
Time Matters on Health Tests [TAT-NGS]
We’re always competing with ourselves on improving turn around time (TAT) because we know patients depend on the results Most studies suggest that treatment delay
July 17, 2019 11:31 am
Press Releases
Myelodysplastic Syndrome (MDS)
MDS is defined as ineffective hematopoiesis characterized by adequate or increased hematologic elements in bone marrow with peripheral cytopenia. Therefore, the presence of cytopenia in
June 26, 2019 3:00 am